ArticleArthritis & rheumatology (Hoboken, N.J.)2014

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.

Andrew J Kinloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.